After injection, the injection site was pressed for 1 min
Dulaglutide, liraglutide and subcutaneous semaglutide have been approved for reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus with established cardiovascular disease, dulaglutide is approved for use in type 2 diabetes mellitus with multiple risk factors, and both liraglutide and semaglutide have been approved for chronic weight management
This guide walks you through everything you need: who should self-inject, the supplies you'll gather, the four safest injection sites, a detailed step-by-step procedure, aftercare, side effects to watch for, and an FAQ that answers the questions patients ask us most often at ThinWorks
SURMOUNT-4 provided the strongest evidence for continued treatment
06 Inspect the solution Use only if the liquid is clear and colorless
Early recognition of hepatic dysfunction allows for timely intervention and appropriate management decisions